Grant name: Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Funding organization: National Institutes of Health (NIH), National Cancer Institute (NCI)
Total funding amount: Less than $500,000 in direct costs per year
Duration: Maximum project period of 5 years
Primary objective: To integrate imaging and fluid-based tumor monitoring techniques to assess therapy response and treatment resistance.
Funding source: NIH
Funding type: Grant
Significance: Aims to enhance cancer treatment monitoring through innovative methodologies.
Grant frequency: Recurring, with multiple application deadlines.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Non-domestic (non-U.S.) Entities are not eligible to apply.
Non-domestic components of U.S. Organizations are not eligible.
Integration of imaging and fluid-based tumor monitoring techniques.
Assessment of treatment success, failure, or recurrence.
Patients undergoing cancer therapy.
Collaboration among imaging scientists, fluid-based assay developers, and clinical scientists.
Application budgets are limited to less than $500,000 in direct costs per year.
Application due dates: June 5, 2027, with multiple cycles leading up to this date.
Must comply with NIH Grants Policy Statement.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.